BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 30694615)

  • 1. Differences between intravenous iron products: focus on treatment of iron deficiency in chronic heart failure patients.
    Martin-Malo A; Borchard G; Flühmann B; Mori C; Silverberg D; Jankowska EA
    ESC Heart Fail; 2019 Apr; 6(2):241-253. PubMed ID: 30694615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale and design of Ferinject assessment in patients with IRon deficiency and chronic Heart Failure (FAIR-HF) study: a randomized, placebo-controlled study of intravenous iron supplementation in patients with and without anaemia.
    Anker SD; Colet JC; Filippatos G; Willenheimer R; Dickstein K; Drexler H; Lüscher TF; Mori C; von Eisenhart Rothe B; Pocock S; Poole-Wilson PA; Ponikowski P;
    Eur J Heart Fail; 2009 Nov; 11(11):1084-91. PubMed ID: 19875408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of quality of life of patients with heart failure and iron deficiency treated with ferric carboxymaltose: FAIR-HF sub-analysis.
    Gutzwiller FS; Pfeil AM; Comin-Colet J; Ponikowski P; Filippatos G; Mori C; Braunhofer PG; Szucs TD; Schwenkglenks M; Anker SD
    Int J Cardiol; 2013 Oct; 168(4):3878-83. PubMed ID: 23870642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ferric carboxymaltose in patients with heart failure and iron deficiency.
    Anker SD; Comin Colet J; Filippatos G; Willenheimer R; Dickstein K; Drexler H; Lüscher TF; Bart B; Banasiak W; Niegowska J; Kirwan BA; Mori C; von Eisenhart Rothe B; Pocock SJ; Poole-Wilson PA; Ponikowski P;
    N Engl J Med; 2009 Dec; 361(25):2436-48. PubMed ID: 19920054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ferric Carboxymaltose: A Review in Iron Deficiency.
    Scott LJ
    Drugs; 2018 Mar; 78(4):479-493. PubMed ID: 29532438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anaemia and iron deficiency in clinical practice:from cardiology to gastroenterology and beyond].
    Češka R
    Vnitr Lek; 2014 Dec; 60(12):1033-9. PubMed ID: 25692829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron therapy for the treatment of iron deficiency in chronic heart failure: intravenous or oral?
    McDonagh T; Macdougall IC
    Eur J Heart Fail; 2015 Mar; 17(3):248-62. PubMed ID: 25639592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Iron deficiency : a new target in treating chronic heart failure ?].
    Borgeaud M; Perrier A
    Rev Med Suisse; 2016 Oct; 12(535):1747-1751. PubMed ID: 28692214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale and design of the AFFIRM-AHF trial: a randomised, double-blind, placebo-controlled trial comparing the effect of intravenous ferric carboxymaltose on hospitalisations and mortality in iron-deficient patients admitted for acute heart failure.
    Ponikowski P; Kirwan BA; Anker SD; Dorobantu M; Drozdz J; Fabien V; Filippatos G; Haboubi T; Keren A; Khintibidze I; Kragten H; Martinez FA; McDonagh T; Metra M; Milicic D; Nicolau JC; Ohlsson M; Parhomenko A; Pascual-Figal DA; Ruschitzka F; Sim D; Skouri H; van der Meer P; Jankowska EA
    Eur J Heart Fail; 2019 Dec; 21(12):1651-1658. PubMed ID: 31883356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron substitution in the treatment of chronic heart failure.
    Gstrein C; Meyer M; Anabitarte P
    Swiss Med Wkly; 2017; 147():w14453. PubMed ID: 28695549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron deficiency in heart failure.
    Dinatolo E; Dasseni N; Metra M; Lombardi C; von Haehling S
    J Cardiovasc Med (Hagerstown); 2018 Dec; 19(12):706-716. PubMed ID: 30222663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening, diagnosis and treatment of iron deficiency in chronic heart failure: putting the 2016 European Society of Cardiology heart failure guidelines into clinical practice.
    McDonagh T; Damy T; Doehner W; Lam CSP; Sindone A; van der Meer P; Cohen-Solal A; Kindermann I; Manito N; Pfister O; Pohjantähti-Maaroos H; Taylor J; Comin-Colet J
    Eur J Heart Fail; 2018 Dec; 20(12):1664-1672. PubMed ID: 30311713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron deficiency in chronic heart failure: case-based practical guidance.
    Lam CSP; Doehner W; Comin-Colet J;
    ESC Heart Fail; 2018 Oct; 5(5):764-771. PubMed ID: 30073785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron Deficiency in Heart Failure: An Overview.
    von Haehling S; Ebner N; Evertz R; Ponikowski P; Anker SD
    JACC Heart Fail; 2019 Jan; 7(1):36-46. PubMed ID: 30553903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Cost-effectiveness Analysis of Ferric Carboxymaltose in Patients With Iron Deficiency and Chronic Heart Failure in Spain.
    Comín-Colet J; Rubio-Rodríguez D; Rubio-Terrés C; Enjuanes-Grau C; Gutzwiller FS; Anker SD; Ponikowski P
    Rev Esp Cardiol (Engl Ed); 2015 Oct; 68(10):846-51. PubMed ID: 25649970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ferric carboxymaltose: a review of its use in iron deficiency.
    Keating GM
    Drugs; 2015 Jan; 75(1):101-27. PubMed ID: 25428711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Budget impact of intravenous ferric carboxymaltose in patients with chronic heart failure and iron deficiency in France.
    Bourguignon S; Faller M; Champs FO; Moutier H; Levesque K; Caranhac G; Cohen-Solal A
    ESC Heart Fail; 2019 Jun; 6(3):559-569. PubMed ID: 31021531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ferric Carboxymaltose in Iron-Deficient Patients with Hospitalized Heart Failure and Reduced Kidney Function.
    Macdougall IC; Ponikowski P; Stack AG; Wheeler DC; Anker SD; Butler J; Filippatos G; Göhring UM; Kirwan BA; Kumpeson V; Metra M; Rosano G; Ruschitzka F; van der Meer P; Wächter S; Jankowska EA
    Clin J Am Soc Nephrol; 2023 Sep; 18(9):1124-1134. PubMed ID: 37382961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of intravenous ferric carboxymaltose on renal function: an analysis of the FAIR-HF study.
    Ponikowski P; Filippatos G; Colet JC; Willenheimer R; Dickstein K; Lüscher T; Gaudesius G; von Eisenhart Rothe B; Mori C; Greenlaw N; Ford I; Macdougall I; Anker SD;
    Eur J Heart Fail; 2015 Mar; 17(3):329-39. PubMed ID: 25683972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ferric carboxymaltose on hospitalization and mortality outcomes in chronic heart failure: A meta-analysis.
    Dalal J; Katekhaye V; Jain R
    Indian Heart J; 2017; 69(6):736-741. PubMed ID: 29174251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.